JP2004500353A5 - - Google Patents

Download PDF

Info

Publication number
JP2004500353A5
JP2004500353A5 JP2001541503A JP2001541503A JP2004500353A5 JP 2004500353 A5 JP2004500353 A5 JP 2004500353A5 JP 2001541503 A JP2001541503 A JP 2001541503A JP 2001541503 A JP2001541503 A JP 2001541503A JP 2004500353 A5 JP2004500353 A5 JP 2004500353A5
Authority
JP
Japan
Prior art keywords
drug
agent
medicament
hair
agent according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001541503A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004500353A (ja
JP4713805B2 (ja
Filing date
Publication date
Priority claimed from DE19957710A external-priority patent/DE19957710A1/de
Application filed filed Critical
Publication of JP2004500353A publication Critical patent/JP2004500353A/ja
Publication of JP2004500353A5 publication Critical patent/JP2004500353A5/ja
Application granted granted Critical
Publication of JP4713805B2 publication Critical patent/JP4713805B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001541503A 1999-11-30 2000-11-29 アンドロゲン性およびびまん性脱毛症の治療のためのメラトニンの使用 Expired - Fee Related JP4713805B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19957710.2 1999-11-30
DE19957710A DE19957710A1 (de) 1999-11-30 1999-11-30 Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US09/506,442 2000-02-18
US09/506,442 US6281241B1 (en) 1999-11-30 2000-02-18 Use of melatonin for the treatment of androgenetic alopecia
PCT/EP2000/011976 WO2001039771A1 (de) 1999-11-30 2000-11-29 Verwendung von melatonin zur behandlung der androgenetischen und diffusen alopezie

Publications (3)

Publication Number Publication Date
JP2004500353A JP2004500353A (ja) 2004-01-08
JP2004500353A5 true JP2004500353A5 (cg-RX-API-DMAC7.html) 2007-12-06
JP4713805B2 JP4713805B2 (ja) 2011-06-29

Family

ID=7930930

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001541503A Expired - Fee Related JP4713805B2 (ja) 1999-11-30 2000-11-29 アンドロゲン性およびびまん性脱毛症の治療のためのメラトニンの使用

Country Status (12)

Country Link
US (2) US6281241B1 (cg-RX-API-DMAC7.html)
EP (1) EP1235571B1 (cg-RX-API-DMAC7.html)
JP (1) JP4713805B2 (cg-RX-API-DMAC7.html)
AT (1) ATE275400T1 (cg-RX-API-DMAC7.html)
AU (1) AU2838101A (cg-RX-API-DMAC7.html)
CA (1) CA2392620C (cg-RX-API-DMAC7.html)
DE (2) DE19957710A1 (cg-RX-API-DMAC7.html)
DK (1) DK1235571T3 (cg-RX-API-DMAC7.html)
ES (1) ES2228663T3 (cg-RX-API-DMAC7.html)
PT (1) PT1235571E (cg-RX-API-DMAC7.html)
TR (1) TR200402628T4 (cg-RX-API-DMAC7.html)
WO (1) WO2001039771A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19957710A1 (de) * 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US6734552B2 (en) 2001-07-11 2004-05-11 Asat Limited Enhanced thermal dissipation integrated circuit package
US7015072B2 (en) 2001-07-11 2006-03-21 Asat Limited Method of manufacturing an enhanced thermal dissipation integrated circuit package
US6790710B2 (en) 2002-01-31 2004-09-14 Asat Limited Method of manufacturing an integrated circuit package
US20030178719A1 (en) * 2002-03-22 2003-09-25 Combs Edward G. Enhanced thermal dissipation integrated circuit package and method of manufacturing enhanced thermal dissipation integrated circuit package
US6940154B2 (en) * 2002-06-24 2005-09-06 Asat Limited Integrated circuit package and method of manufacturing the integrated circuit package
JP2006513255A (ja) * 2002-10-30 2006-04-20 アサト　アクチェンゲゼルシャフト　アプライド　サイエンス　アンド　テクノロジー メラトニン、イチョウおよびビオチンを含有する調製物
RU2336873C2 (ru) * 2002-10-30 2008-10-27 Азат Аг Апплайд Сайенс Энд Текнолоджи Дозаторы суточных доз мелатонина
US20050249785A1 (en) * 2003-08-13 2005-11-10 Gordon John G Use of melatonin-containing oral supplement with animals
MXPA06009377A (es) * 2004-02-20 2007-03-07 Lifescape Biosciences Inc Composiciones y metodos para regulacion del sueno.
JP3964417B2 (ja) * 2004-09-27 2007-08-22 国立大学法人金沢大学 インドール誘導体を有効成分とするα２受容体遮断剤及び血管拡張剤
US20080059313A1 (en) * 2006-08-30 2008-03-06 Oblong John E Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
ITGE20070009A1 (it) * 2007-01-24 2008-07-25 Leila Baeram Composizione cosmetica e metodo per favorire la ricrescita dei capelli.
US20100120871A1 (en) * 2008-11-10 2010-05-13 Dawson Jr Thomas Larry Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
GB0918564D0 (en) 2009-10-22 2009-12-09 Plasticell Ltd Nested cell encapsulation
WO2011109459A2 (en) * 2010-03-04 2011-09-09 University Of Miami Compositions, kits and methods for determining efficacy of a therapeutic agent and treating hair and skin diseases
ITMI20112432A1 (it) * 2011-12-30 2013-07-01 Bionest Ltd Kit per il trattamento e la prevenzione dell'alopecia
US11696883B2 (en) 2014-05-23 2023-07-11 Triple Hair Inc. Compositions for reducing hair loss and/or increasing hair regrowth
WO2015176161A1 (en) 2014-05-23 2015-11-26 Triple Hair Inc. Compositions for reducing hair loss and/or increasing hair regrowth
WO2016166047A1 (en) 2015-04-14 2016-10-20 Phyture Biotech, S.L. Cell-free plant cell culture suspension supernatant with re-youth activity and/or wound healing activity over skin cells
ES2902842T3 (es) 2015-07-08 2022-03-30 Triple Hair Inc Composición que comprende resveratrol y melatonina para reducir la caída y/o aumentar el crecimiento del cabello
BR112018070819A2 (pt) 2016-04-11 2019-02-05 Vytrus Biotech S L peptídeos e composições farmacêuticas, nutracêuticas ou veterinárias para prevenção e/ou tratamento de queda de cabelo
GB201707143D0 (en) 2017-05-04 2017-06-21 Plasticell Ltd Method for producing cells
GB2638109A (en) * 2022-06-20 2025-08-20 John Hemming Trading Ltd Cell differentiation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340579A (en) * 1984-11-20 1994-08-23 Farmaka S.R.L. Method of treating dermatological conditions
US4746674A (en) 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
JPS61212512A (ja) * 1985-03-19 1986-09-20 Shiseido Co Ltd 養毛料
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
FR2717381B1 (fr) * 1994-03-15 1996-04-19 Oreal Compositions à base d'alpha-pyrones pour induire et stimuler la croissance des cheveux et/ou freiner leur chute et utilisation.
JP3108586B2 (ja) * 1994-06-01 2000-11-13 富士産業株式会社 育毛剤
US5597575A (en) * 1994-06-06 1997-01-28 Breitbarth; Richard Composition for stimulating and inducing hair growth
DE19509354A1 (de) * 1994-12-08 1996-06-13 Klett Loch Lore M Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall
US5792785A (en) * 1995-11-24 1998-08-11 Equitech Laboratories, Inc. Method for enhancing pregnancy success in an animal
ES2101660B1 (es) * 1995-12-21 1997-12-16 Soler Armando Jose Yanez Nuevo crecepelo de uso topico.
GB2314019B (en) * 1996-06-10 2000-03-15 Bio Scient Ltd The use of L-Lysine in the treatment of hair loss
FR2751539B1 (fr) * 1996-07-25 1998-12-04 Oreal Nouvelles compositions topiques comprenant de tres faibles doses de melatonine ou ses derives et leur utilisation en cosmetique
WO1998005298A1 (es) * 1996-08-02 1998-02-12 Universidad De Granada Desarrollo de productos cosmeticos para uso humano a base de melatonina como producto activo
FR2754454B1 (fr) * 1996-10-10 1998-11-27 Oreal Utilisation d'au moins un glycol comme agent de solubilisation de la melatonine dans l'eau et compositions obtenues
FR2756832B1 (fr) * 1996-12-06 1999-01-08 Oreal Utilisation de melatonine dans une composition pour stabiliser les polymeres gelifiants hydrophiles
US5958964A (en) * 1997-02-18 1999-09-28 South Alabama Medical Science Foundation Use of melatonin to prevent cytotoxic effects of amyloid beta protein
US6030948A (en) * 1997-12-19 2000-02-29 Mann; Morris A. Hair regeneration compositions for treatment of alopecia and methods of application related thereto
WO1999048489A2 (en) * 1998-03-25 1999-09-30 South Alabama Medical Science Foundation Melatonin for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders
DE19957710A1 (de) * 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US6747008B1 (en) * 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux

Similar Documents

Publication Publication Date Title
JP2004500353A5 (cg-RX-API-DMAC7.html)
US5898037A (en) Formulations of magnesium compounds for local application and methods of treatment using the same
KR100924476B1 (ko) 국소 글리코피롤레이트 제품
JP4031513B2 (ja) 改良された発熱性化粧品組成物
US20090214628A1 (en) Methods and compositions for treatment of skin
JP2002521320A5 (ja) 皮膚の脂質産生を促進するための組成物
JP2004505007A5 (cg-RX-API-DMAC7.html)
JP2002512971A5 (cg-RX-API-DMAC7.html)
Weinstein Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
MXPA04000654A (es) Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
EP0954278A1 (en) Pharmaceutical compositions containing kukui nut oil
EP1948236A2 (en) Methods and compositions for treatment of skin
JP2006513255A (ja) メラトニン、イチョウおよびビオチンを含有する調製物
CN1292699A (zh) 皮肤刺激的处理方法
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
US20110236503A1 (en) Topical Skincare Composition
JP2004501939A5 (cg-RX-API-DMAC7.html)
US6702733B1 (en) Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds
US6465514B1 (en) Methods and compositions for the promotion of hair growth
PL370309A1 (en) A wound care device
AU2005262354B2 (en) Cosmetic compositions and methods for sensory cooling
JP2003523397A5 (cg-RX-API-DMAC7.html)
WO2009101497A2 (en) Topical pharmaceutical combination comprising minoxidil and aminexil
JP2002530327A5 (cg-RX-API-DMAC7.html)